| Name | Title | Contact Details |
|---|
Citra is a health solutions company providing a one-contract, connected solution for clinical, financial and administrative requirements. Solving for the needs of providers, payers, health systems and employers in the transition to value-based care, Citra empowers clients with proven technology, population health, analytics, care management, and administrative services to strategically expand market opportunity, diversify revenue streams, and lower the cost of care and improve quality. Serving 6 of the top 7 Health Plans; 7 Fortune 500 Companies; 50+ IPAs and MSOs managing commercial, Medicare and Medicaid populations; 100+ Provider Groups, Hospitals, Universities and Integrated Delivery Networks throughout the United States and in Puerto Rico. Citra delivers technology and services resulting in more efficient operations and higher quality care. Our vision is for providers, health systems, payers, and employers to embrace the transformation of healthcare payment models using our cohesive clinical, financial and administrative solutions.ical, financial and administrative solutions.
St. Francis Health Center is a Topeka, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Jacksonville, FL, Healogics is the nation`s largest provider of advanced wound care services. Healogics and its affiliated companies manage a network of Wound Care Centers® through-out the United States and the United Kingdom. Healogics technology-enabled wound care model supports the critical connection between patients with chronic wounds and multi-disciplinary teams for continuous, collaborative, patient-centered care.
Aperio is committed to attracting and retaining the most highly qualified candidates available. As an Aperio employee you will be consistently challenged to deliver your best.
Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.